Clinical Trials Browser

Phase 3 × Bortezomib × Gastrointestinal × Clear all

NCT03345303 2017-11-17

Bortezomib in Intrahepatic Cholangiocellular Carcinoma

Phase 3 Unknown

Gastrointestinal

Cholangiocarcinoma